WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005111037) BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/111037    International Application No.:    PCT/US2005/013812
Publication Date: 24.11.2005 International Filing Date: 08.04.2005
IPC:
C07D 471/04 (2006.01), A61K 31/5377 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01)
Applicants: MILLENNIUM PHARMACEUTICALS, INC. [US/US]; 40 Landsdowne Street, Cambridge, MA 02139 (US) (For All Designated States Except US).
HEPPERLE, Michael, E. [DE/US]; (US) (For US Only).
LIU, Julie, Fields [US/US]; (US) (For US Only).
SOUCY, Francois [CA/US]; (US) (For US Only).
PRAKASH, Raman [IN/US]; (US) (For US Only).
LITTLE, Jeremy, D. [US/US]; (US) (For US Only).
FLEMING, Paul, E. [US/US]; (US) (For US Only).
REYNOLDS, Dominic [GB/US]; (US) (For US Only).
HARRIMAN, Geraldine, C., B. [US/US]; (US) (For US Only)
Inventors: HEPPERLE, Michael, E.; (US).
LIU, Julie, Fields; (US).
SOUCY, Francois; (US).
PRAKASH, Raman; (US).
LITTLE, Jeremy, D.; (US).
FLEMING, Paul, E.; (US).
REYNOLDS, Dominic; (US).
HARRIMAN, Geraldine, C., B.; (US)
Agent: SHAIR, Karoline, K., M.; Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA 02139 (US)
Priority Data:
60/560,892 09.04.2004 US
Title (EN) BETA-CARBOLINES USEFUL FOR TREATING INFLAMMATORY DISEASE
(FR) UTILISATION DE BETA-CARBOLINES POUR LE TRAITEMENT DE MALADIES INFLAMMATOIRES
Abstract: front page image
(EN)This invention provides beta-carboline compounds of formula III-A-aa, wherein Q, G, R1, R2, R3, and R6b are as described in the specification. The compounds are useful for treating diseases such as inflammatory diseases and cancer.
(FR)L'invention porte sur des composés à base de bêta carbolines de formule III-A-aa, dans laquelle: Q, G, R1, R2, R3, et R6b sont décrits dans la spécification. Lesdits composés s'avérant utiles pour le traitement de maladies inflammatoires et du cancer.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)